Migrating glioma cells express stem cell markers and give rise to new tumors upon xenografting

Glioblastoma (GBM) is the most frequent and malignant brain tumor with an overall survival of only 14.6 months. Although these tumors are treated with surgery, radiation and chemotherapy, recurrence is inevitable. A critical population of tumor cells in terms of therapy, the so-called cancer stem ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Munthe, Sune, Sørensen, Mia D., Thomassen, Mads, Burton, Mark, Kruse, Torben A., Lathia, Justin D., Poulsen, Frantz Rom, Kristensen, Bjarne Winther
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Laboratory Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069331/
https://www.ncbi.nlm.nih.gov/pubmed/27510953
http://dx.doi.org/10.1007/s11060-016-2221-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069331/
https://www.ncbi.nlm.nih.gov/pubmed/27510953
http://dx.doi.org/10.1007/s11060-016-2221-y

Ejemplares similares